Products for Research Use Only
RegisterLogin

(S) -Cdc7-IN-18

CAT: 0804-HY-143432ASize: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-143432ASize:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
(S) -Cdc7-IN-18 is a potent inhibitor of CDC7. Overexpression of huCdc7 promotes overactivation of MCM2, an important marker of tumor cells, and thus promotes aberrant proliferation of tumor cells. (S) -Cdc7-IN-18 has the potential for the research of cancer diseases (extracted from patent WO2020239107A1, compound 1-1) [1].
CAS Number
2562329-13-7
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/s-cdc7-in-18.html
Solubility
10 mM in DMSO
Smiles
O=C1C2=C(NC([C@@]3([H])N4CCC(CC4)C3)=N1)C5=C(C6=CNN=C6CCC5)S2
Molecular Formula
C19H21N5OS
Molecular Weight
367.47
References & Citations
[1]Gang Li, et al. Tetracyclines as Cdc7 inhibitors. Patent WO2020239107A1.|[2]Li Gang, et al. Tetracyclic compounds as cdc7 inhibitors. WO2020239107A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDC

Related Products

CatalogName
HY-143432Cdc7-IN-18
HY-N16011-0118:1 BMP (S, S) (ammonium)
HY-N1601718:1 BDP (S, S) (ammonium)
HY-16602418 (S) -Methyleicosanoic acid
HY-143433Cdc7-IN-19
HY-143431Cdc7-IN-17
HY-101523-01Cdc7-IN-1
HY-130517-01Cdc7-IN-5
HY-143383Cdc7-IN-11
HY-143385Cdc7-IN-12

Alternative Products

CatalogName
T61436-01Cdc7-IN-18
T61435-01(S) -Cdc7-IN-18
MBS5804139(S)-Cdc7-IN-18
310131CDC7
BA3857-1Cdc7-IN-7
BA3833-25Cdc7-IN-5
CGC05525-01Cdc7-IN-1
310132CDC7 discontinued
T61288-01Cdc7-IN-13
MBS8513698-01CDC7 Antibody

Popular Products